MedTrace Logo

Study of Glycopyrronium in Axillary Hyperhydrosis

NCT02530281 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 344

Last updated 2021-08-25

Study results available
· View outcomes & findings →

Summary

The study is a randomized, double-blind, vehicle controlled, parallel group study, designed to assess the efficacy and safety of glycopyrronium topical wipes, once daily, compared to vehicle in subjects with axillary hyperhidrosis.

Conditions

  • Hyperhidrosis

Interventions

DRUG

glycopyrronium Topical Wipes

Topical wipes containing glycopyrronium

OTHER

Vehicle

Vehicle (placebo) topical wipes

Sponsors & Collaborators

  • Journey Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Lynne M Deans, MT · Dermira, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02530281 on ClinicalTrials.gov